BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6240223)

  • 1. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
    Haase DA; Harding GK; Thomson MJ; Kennedy JK; Urias BA; Ronald AR
    Antimicrob Agents Chemother; 1984 Oct; 26(4):481-4. PubMed ID: 6240223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
    Schaeffer AJ; Sisney GA
    J Urol; 1985 Apr; 133(4):628-30. PubMed ID: 3157008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
    Guerra JG; Falconi E; Palomino JC; Benavente L; Antunez de Mayolo E
    Eur J Clin Microbiol; 1983 Jun; 2(3):260-5. PubMed ID: 6224684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
    Watt B; Chait I; Kelsey MC; Newsom SW; Newsom RA; Smith J; Toase PD; Deaney NB; Round EM; Vogel R
    J Antimicrob Chemother; 1984 May; 13 Suppl B():89-94. PubMed ID: 6234281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
    Vogel R; Deaney NB; Round EM; VandenBurg MJ; Currie WJ
    J Antimicrob Chemother; 1984 May; 13 Suppl B():113-20. PubMed ID: 6234271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
    Goldstein EJ; Alpert ML; Ginsberg BP
    Antimicrob Agents Chemother; 1985 Mar; 27(3):422-3. PubMed ID: 3158277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
    Sabbaj J; Hoagland VL; Shih WJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):297-301. PubMed ID: 3158272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.
    Giamarellou H; Tsagarakis J; Petrikkos G; Daikos GK
    Eur J Clin Microbiol; 1983 Jun; 2(3):266-9. PubMed ID: 6224685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimicrobial spectrum of norfloxacin.
    Newsom SW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():25-31. PubMed ID: 6234272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and tolerance of norfloxacin compared with trimethoprim-sulfamethoxazole in the treatment of uncomplicated urinary tract infections].
    Ballesteros JJ; Salvador M; Macías J; Honorato J; Rubio A; Azanza JR
    Rev Med Univ Navarra; 1988; 32(3):135-7. PubMed ID: 3070683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of urinary tract infection in the elderly.
    Bendall MJ
    J Antimicrob Chemother; 1984 May; 13 Suppl B():69-78. PubMed ID: 6234278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections.
    Mavromanolakis E; Maraki S; Samonis G; Tselentis Y; Cranidis A
    J Chemother; 1997 Jun; 9(3):203-7. PubMed ID: 9210003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.
    Iravani A; Richard GA; Baer H; Fennell R
    Antimicrob Agents Chemother; 1981 Apr; 19(4):598-604. PubMed ID: 6972732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the treatment of simple urinary infection with a single dose of norfloxacin versus cotrimoxazole].
    de Vevey P; Darioli R; Bille J; Glauser MP
    Schweiz Med Wochenschr; 1987 Jun; 117(25):968-73. PubMed ID: 3497450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.
    Rylander M; Norrby SR; Svärd R
    Scand J Infect Dis; 1987; 19(5):551-7. PubMed ID: 3321412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
    J Infect Dis; 1987 Feb; 155(2):170-7. PubMed ID: 2879872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nalidixic acid and trimethoprim/sulphamethoxazole as alternatives for short-term treatment of urinary infections.
    Zaki M; Helin I
    Ann Trop Paediatr; 1986 Sep; 6(3):205-7. PubMed ID: 2430512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
    Stein GE; Mummaw N; Goldstein EJ; Boyko EJ; Reller LB; Kurtz TO; Miller K; Cox CE
    Arch Intern Med; 1987 Oct; 147(10):1760-2. PubMed ID: 3310941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of Mictral with co-trimoxazole in the treatment of urinary tract infections.
    Healey JC
    Practitioner; 1982 Nov; 226(1373):1971-4. PubMed ID: 6760166
    [No Abstract]   [Full Text] [Related]  

  • 20. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
    Sabbaj J; Hoagland VL; Cook T
    Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.